Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Medical Marijuana Got A Major Federal Upgrade

For the first time in more than 50 years, the federal government has fundamentally changed how it classifies medical marijuana, and for millions of patients and researchers, this is a very big deal. Effective April 28, 2026, the Justice Department and the Drug Enforcement Administration officially moved FDA-approved cannabis products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. Schedule I — the most restrictive category, reserved for substances with “no accepted medical use” — is where marijuana has sat since 1970, alongside heroin. Moving to Schedule III, the same category as ketamine and certain anabolic steroids, is a landmark shift that recognizes what 40 U.S. states have already acknowledged for years: medical marijuana has genuine therapeutic value. For patients, the change could improve access and affordability, as medical cannabis businesses will no longer face a punishing tax rule that had effectively prohibited them from deducting standard business expenses, often pushing effective federal tax rates on those businesses as high as 70 to 80 percent.

For scientists, the rescheduling is equally significant. Schedule I status has long created enormous barriers to cannabis research, making it exceptionally difficult to study a substance tens of millions of Americans already use. Researchers studying everything from chronic pain to epilepsy to PTSD have faced federal restrictions that simply don’t apply to other substances under study. Those barriers will now ease meaningfully. A DEA administrative hearing beginning June 29, 2026, will consider whether the rescheduling extends to all marijuana — including recreational products. For now, the immediate and historic win belongs to the patients, doctors, and researchers who have long argued that science, not stigma, should drive federal drug policy.

Source: https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268

PrevPreviousA Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer
NextA Gamer Just Broke A 14-Year-Old Record By Playing Super Mario For 60 Hours StraightNext

Recent Articles

Happy News

Eating Eggs Regularly May Cut Alzheimers Risk By Up To 27 Percent

May 9, 2026

A new study from Loma Linda University Health has found that adults 65 and older who eat eggs regularly have a significantly lower risk of developing Alzheimer’s disease, with people who consumed at least one egg per day for five or more days a week showing up to a 27

Read More
Happy News

Birdwatching Among Gen Z In Britain Has Grown By Over 1000 Percent Since 2018 And The Reasons Why Are Beautiful

May 8, 2026

Birdwatching has quietly become one of the fastest-growing hobbies among young people in Britain, with new research from the Royal Society for the Protection of Birds finding that nearly 750,000 people aged 16 to 29 now birdwatch regularly, a staggering increase of more than 1,000 percent since 2018. The study

Read More
Happy News

Meet The Record Holders Who Prove That Age Is Genuinely Just A Number

May 8, 2026

Guinness World Records has published a new feature celebrating some of the most extraordinary older athletes on the planet, a collection of record holders that makes a compelling case that age really is just a number. Leading the group is Mathea Allansmith of Hawaii, born in 1930, who took up

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.